This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Luzzatto, G. Articles by Cella, G. Search for Related Content PubMed PubMed Citation Articles by Luzzatto, G. Articles by Cella, G. Social Bookmarking                         What's this?

Effects of Glycosaminoglycans and Protamine Chloridrate on Platelet Aggregation Induced by Collagen and Thrombin

Institute of Medical Semeiotics, Second Chair of Medicine, University of Padua, Medical School, Padua, Italy

Rossella Paolini

Institute of Medical Semeiotics, Second Chair of Medicine, University of Padua, Medical School, Padua, Italy

Francesco Stevanato

Institute of Medical Semeiotics, Second Chair of Medicine, University of Padua, Medical School, Padua, Italy

Paolo Simioni

Institute of Medical Semeiotics, Second Chair of Medicine, University of Padua, Medical School, Padua, Italy

Giuseppe Cella

Institute of Medical Semeiotics, Second Chair of Medicine, University of Padua, Medical School, Padua, Italy

The effects of heparin (HE), dermatan sulfate (DS), heparan sulfate (HS) and protamine chloridrate (PC) on platelet aggregation were studied. Both PC and the three glycosaminoglycans (GAGs) did not influence collagen-induced platelet aggregation. In contrast, all the tested GAGs blocked thrombin-induced platelet aggregation. HE and HS were equivalent and very effective, while DS was also but to a lesser extent. This could be because HE and HS act via both antithrombin III and heparin-cofactor II, whereas DS exerts its action on the latter only. PC, too, inhibited, in a dose-dependent fashion, thrombin-induced platelet aggregation, probably by competing with the thrombin affinity binding sites on the platelet surface. When the GAGs were tested together with PC, HE was shown to be the most effective: on a weight-for-weight basis, an identical amount of PC was unable to counteract the inhibitory effect of HE, while it partially reversed those of DS and HS. A full reversal of the inhibitory effect of DS and HS was never observed, in spite of adding increasing amounts of PC. It seems likely that plasma components may preserve the bindings of such GAGs with their cofactors.

Angiology, Vol. 40, No. 3, 170-174 (1989)
DOI: 10.1177/000331978904000303


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?